Natural Selection

Michael Behe (Letters, The Scientist, June 9, 1997, page 10) pulls many of the creationists' favorite tricks, albeit understated or in disguise, to sow doubt about evolution. He says that "common descent cannot be conclusively proved." By doing so, he uses the creationist ploy of misstating the way science works. Because science usually speaks in terms of probabilities and the weight of evidence rather than absolute certainties, it's an easy target. Behe also takes a glancing shot at the fossi

Written byBarry Palevitz
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Michael Behe (Letters, The Scientist, June 9, 1997, page 10) pulls many of the creationists' favorite tricks, albeit understated or in disguise, to sow doubt about evolution.

He says that "common descent cannot be conclusively proved." By doing so, he uses the creationist ploy of misstating the way science works. Because science usually speaks in terms of probabilities and the weight of evidence rather than absolute certainties, it's an easy target. Behe also takes a glancing shot at the fossil record, calling it "spotty." Any paleontologist will admit that the record is far from complete, but like a puzzle whose pieces are inexorably filled in, the picture is becoming ever clearer, and that picture is fully consistent with evolution through common descent. It's even more convincing in light of recent work on molecular phylogeny. Behe may be "in the dark," but for nearly all of the biological community, the light ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies